Senior insider sale
ARROWHEAD PHARMACEUTICALS, INC. — senior position signals high conviction
$173.9K
2K shares
What this filing means
OLUKOTUN ADEOYE Y plans to sell 2K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $173.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/18/2026ACC: 0001628280-26-057774
Director
Since Sep 2020
2K
Shares to sell
$173.9K
Approx. market value
2K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Compensation
Compensation
12/18/2025
2KTotal acquired2K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/18/2025 | Compensation Compensation | 2K | — |
| Total | 2K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2K
Market value
$173.9K
8/18/2026
Total
Units
2K
Value
$173.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/18/2026 | 2K | $173.9K | NASDAQ | Planned |
| Total | 2K | $173.9K | ||